Patents by Inventor Xu Wen Chen

Xu Wen Chen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of IL-22 for the treatment of conditions of metabolic disorders
    Patent number: 7718604
    Abstract: The use of IL-22 for the treatment of metabolic disorders including hyperlipidemia, obesity, hyperinsulinemia and diabetes. IL-22 may also be used in combination with insulin for diabetes.
    Type: Grant
    Filed: November 16, 2007
    Date of Patent: May 18, 2010
    Assignee: DHY & Co., Ltd.
    Inventors: Yu Liang Huang, Xu Wen Chen
  • Use of IL-22 for the treatment of conditions of metabolic disorders
    Patent number: 7696158
    Abstract: The use of IL-22 for the treatment of metabolic disorders including hyperlipidemia, obesity, hyperinsulinemia and diabetes. IL-22 may also be used in combination with insulin for diabetes.
    Type: Grant
    Filed: November 16, 2007
    Date of Patent: April 13, 2010
    Assignee: DHY & Co., Ltd.
    Inventors: Yu Liang Huang, Xu Wen Chen
  • Use of IL-22 for the treatment of conditions of metabolic disorders
    Patent number: 7666402
    Abstract: The use of IL-22 for the treatment of metabolic disorders including hyperlipidemia, obesity, hyperinsulinemia and diabetes. IL-22 may also be used in combination with insulin for diabetes.
    Type: Grant
    Filed: November 16, 2007
    Date of Patent: February 23, 2010
    Assignee: DHY & Co., Ltd.
    Inventors: Yu Liang Huang, Xu Wen Chen
  • USE OF IL-22 FOR THE TREATMENT OF CONDITIONS OF METABOLIC DISORDERS
    Publication number: 20100015086
    Abstract: The use of IL-22 for the treatment of metabolic disorders including hyperlipidemia, obesity, hyperinsulinemia and diabetics. IL-22 may also be used in combination with insulin for diabetics.
    Type: Application
    Filed: August 8, 2005
    Publication date: January 21, 2010
    Inventors: Yu Liang Huang, Xu Wen Chen
  • ANTIBODIES AGAINST INTERLEUKIN-22 BINDING PROTEIN AND ITS USES FOR THE TREATMENT OF METABOLIC DISORDERS
    Publication number: 20090148440
    Abstract: The present invention relates to antibodies and antigen-binding fragments that bind to interleukin-22 binding protein, in particular, human interleukin-22 binding protein (IL-22 BP), and are involved in regulating interleukin-22-associated biological responses. The invention also relates to methods of using the antibodies and antigen-binding fragments to treat disorders associated with interleukin-22. The antibodies disclosed herein are useful in diagnosing, preventing, or treating metabolic disorders including obesity, diabetes, hyperlipidemia and hyperinsulinemia etc.
    Type: Application
    Filed: December 21, 2006
    Publication date: June 11, 2009
    Applicant: DHY & CO., LTD.
    Inventors: Yu Liang Huang, Xu Wen Chen, Zhi Hua Huang
  • USE OF IL-22 FOR THE TREATMENT OF CONDITIONS OF METABOLIC DISORDERS
    Publication number: 20080138314
    Abstract: The use of IL-22 for the treatment of metabolic disorders including hyperlipidemia, obesity, hyperinsulinemia and diabetes. IL-22 may also be used in combination with insulin for diabetes.
    Type: Application
    Filed: November 16, 2007
    Publication date: June 12, 2008
    Inventors: Yu Liang HUANG, Xu Wen Chen